FDA Official and Industry Show Linkages Between QbD and Clinical Performance
This article was originally published in The Gold Sheet
Executive Summary
Quality by design could prevent recalls and market withdrawals, suggests FDA's Mansoor Khan, citing alcohol dumping, impurity and degradation cases. Abbott and Merck experts explore potential of in vitro in vivo correlations for linking drug quality to safety and efficacy.